Speakers

Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV

Ad Antonisse | Director Market Access & External Affairs | AstraZeneca BV » speaking at World EPA Congress

Fausto Artico, Global R&D Tech Head of Innovation and Data Science, GSK

Fausto Artico | Global R&D Tech Head of Innovation and Data Science | GSK » speaking at World EPA Congress

Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group

Marnix Artz | Head of Patient Access, Pricing & Public Affairs, Netherlands | Merck Group » speaking at World EPA Congress

Dorothee Bartels, Global Head RWE, UCB

Dorothee Bartels | Global Head RWE | UCB » speaking at World EPA Congress

Alexander Bastian, VP Value & Market Access, A.M. Pharma

Alexander Bastian | VP Value & Market Access | A.M. Pharma » speaking at World EPA Congress

Tomer Ben Zaken, Regional Business Operation Lead, Takeda

Tomer Ben Zaken | Regional Business Operation Lead | Takeda » speaking at World EPA Congress

Mr Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, Teva Pharmaceuticals

Mr Jesper Bjerggren | European Market Access Lead Respiratory/Digital Health | Teva Pharmaceuticals » speaking at World EPA Congress

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Axel Boehnke | Director Market Access EU North | PTC Therapeutics » speaking at World EPA Congress

Amanda Bok, Chief Executive Officer, European Haemophilia Consortium

Amanda Bok | Chief Executive Officer | European Haemophilia Consortium » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Vidya Breeveld, Founder, Transmineo

Vidya Breeveld | Founder | Transmineo » speaking at World EPA Congress

Irena Brookes-Smith, Senior Director RWE Strategy & Capabilities, AstraZeneca

Irena Brookes-Smith | Senior Director RWE Strategy & Capabilities | AstraZeneca » speaking at World EPA Congress

Sandro Cesaro, Head, Market Access and Innovative Value Strategies, Oncology Europe, AstraZeneca

Sandro Cesaro | Head, Market Access and Innovative Value Strategies, Oncology Europe | AstraZeneca » speaking at World EPA Congress

Mata Charokopou, Head of Payer value Strategy, UCB

Mata Charokopou | Head of Payer value Strategy | UCB » speaking at World EPA Congress

Ms Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion

Ms Helene Chevrou-Severac | HEOR RWE Centre of Excellence Head, International & Japan | Alexion » speaking at World EPA Congress

José Luis Sánchez Chorro, Market Access Director Spain and Portugal, Jazz Pharmaceuticals

José Luis Sánchez Chorro | Market Access Director Spain and Portugal | Jazz Pharmaceuticals » speaking at World EPA Congress

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at World EPA Congress

Frederic Ernst, Head of Market Access for Europe, Santen

Frederic Ernst | Head of Market Access for Europe | Santen » speaking at World EPA Congress

Gina Ewy, Market Access, Hansa Biopharma

Gina Ewy | Market Access | Hansa Biopharma » speaking at World EPA Congress

Graham Foxon, Managing Director, remap consulting

Graham Foxon | Managing Director | remap consulting » speaking at World EPA Congress

Philippe Ghyssels, VP Corporate and Global Public Affairs, Ipsen

Philippe Ghyssels | VP Corporate and Global Public Affairs | Ipsen » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Janssen

Christoph Glaetzer | Chief Global Value and Access Officer | Janssen » speaking at World EPA Congress

Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy

Josie Godfrey | Co-Founder and Chief Executive Officer | Realise Advocacy » speaking at World EPA Congress

Dr Alicia Granados, Global Medical RD Scientific Advocacy Head, Sanofi

Dr Alicia Granados | Global Medical RD Scientific Advocacy Head | Sanofi » speaking at World EPA Congress

Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut

Laura Guarga | Consultant of Pharmacoeconomic Department | CatSalut » speaking at World EPA Congress

Tanja Heidbrede, Head RWE Central EU, UCB

Tanja Heidbrede | Head RWE Central EU | UCB » speaking at World EPA Congress

Pall Jonsson, Programme director for Data, Nice

Pall Jonsson | Programme director for Data | Nice » speaking at World EPA Congress

Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, roche

Gomathi Kaliappan | Health Systems Strategy Leader - Global Access | roche » speaking at World EPA Congress

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator applications » speaking at World EPA Congress

Jolanda Koenders, Head of Patient Value and Access, Takeda Nederland

Jolanda Koenders | Head of Patient Value and Access | Takeda Nederland » speaking at World EPA Congress

Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K

Augusta Elizabeth Koroma | Chief Executive Officer | Sickle cell Intervention U.K » speaking at World EPA Congress

Giovanny Leon, Pricing & Access Regional Director - LatAm & Canada, Novartis AG

Giovanny Leon | Pricing & Access Regional Director - LatAm & Canada | Novartis AG » speaking at World EPA Congress

Herve Lilliu, Chief Executive Officer, Inbeeo

Herve Lilliu | Chief Executive Officer | Inbeeo » speaking at World EPA Congress

Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Elena Lungu | Manager of Policy Development, Patented Medicine Prices Review Board | Government of Canada » speaking at World EPA Congress

James Maddocks, International Policy Advisor, NHS Confederation

James Maddocks | International Policy Advisor | NHS Confederation » speaking at World EPA Congress

Bart Malfait, Director Government Affairs & Market Access (BeLux), Astra Zeneca

Bart Malfait | Director Government Affairs & Market Access (BeLux) | Astra Zeneca » speaking at World EPA Congress

Marco Marchetti, Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas

Marco Marchetti | Director of Health Technology Assessment Unit, National  Agency for Regional Care Services | Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas » speaking at World EPA Congress

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Paolo Morgese | EU Director Market Access & Member Relations | Alliance for Regenerative Medicine » speaking at World EPA Congress

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at World EPA Congress

Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd

Andrew Olaye | Head of EMEA Market Access | Orchard Therapeutics Ltd » speaking at World EPA Congress

Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca

Mario Ouwens | Group Director Medical & Payer Evidence Statistics | AstraZeneca » speaking at World EPA Congress

Francis Pang, VP Global Market Access, Orchard Therapeutics

Francis Pang | VP Global Market Access | Orchard Therapeutics » speaking at World EPA Congress

Michela Pantaleoni, Head of Market Access Rare Diseases Europe & Emerg, Chiesi Global Rare Disease

Michela Pantaleoni | Head of Market Access Rare Diseases Europe & Emerg | Chiesi Global Rare Disease » speaking at World EPA Congress

Julien Patris, Director Market Access & Policy – Europe / Canada / MEA (CEMEA), Alnylam

Julien Patris | Director Market Access & Policy – Europe / Canada / MEA (CEMEA) | Alnylam » speaking at World EPA Congress

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at World EPA Congress

Lara Pippo, Head Of Market Access, Italy, CSL Behring

Lara Pippo | Head Of Market Access, Italy | CSL Behring » speaking at World EPA Congress

Ana Plata, Head of Global Pricing Implementation BBU, AstraZeneca

Ana Plata | Head of Global Pricing Implementation BBU | AstraZeneca » speaking at World EPA Congress

Luis Prieto Rodriguez, Global Real-World Evidence Director, Novartis

Luis Prieto Rodriguez | Global Real-World Evidence Director | Novartis » speaking at World EPA Congress

Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche

Sreeram Ramagopalan | Global Head Real-World Evidence (Market Access) | Roche » speaking at World EPA Congress

Sybille Riou, Global Market Access Manager, Miltenyi Biomedicine

Sybille Riou | Global Market Access Manager | Miltenyi Biomedicine » speaking at World EPA Congress

Sandrine Ruiz, Director Global Market Access and Pricing, Independent

Sandrine Ruiz | Director Global Market Access and Pricing | Independent » speaking at World EPA Congress

Sophie Schmitz, Managing Partner, Partners4Access

Sophie Schmitz | Managing Partner | Partners4Access » speaking at World EPA Congress

Michael Schroter, Co-Head Sustainable Healthcare Equity, Hsbc

Michael Schroter | Co-Head Sustainable Healthcare Equity | Hsbc » speaking at World EPA Congress

Ayman Semaan, Head of Market Access, Biologix

Ayman Semaan | Head of Market Access | Biologix » speaking at World EPA Congress

Navin Sewak, Global Market Access Director, ViiV Healthcare

Navin Sewak | Global Market Access Director | ViiV Healthcare » speaking at World EPA Congress

Helen Stoop, Head of Tender Excellence & PDT Payer Value, Takeda

Helen Stoop | Head of Tender Excellence & PDT Payer Value | Takeda » speaking at World EPA Congress

Jan Swiderski, Public Affairs & Advocacy Director, Ipsen

Jan Swiderski | Public Affairs & Advocacy Director | Ipsen » speaking at World EPA Congress

Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation

Monika Szkultecka-Debek | Vice President | Qualitas Vitae Institute Foundation » speaking at World EPA Congress

Giovanni Tafuri, Director International Market Access and Policy, Apellis Pharmaceuticals

Giovanni Tafuri | Director International Market Access and Policy | Apellis Pharmaceuticals » speaking at World EPA Congress

Ilona Torontali, Global Head Pricing and Reimbursement, Roche

Ilona Torontali | Global Head Pricing and Reimbursement | Roche » speaking at World EPA Congress

Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence

Sheela Upadhyaya | Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist | National Institute for Health and Care Excellence » speaking at World EPA Congress

Andreas Uttenweiler, Head Patient Value Access & Public Affairs, Takeda Pharma AG

Andreas Uttenweiler | Head Patient Value Access & Public Affairs | Takeda Pharma AG » speaking at World EPA Congress

Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences

Bart Van Den Daele | Head of External Affairs – Director Market Access - Belux | Gilead Sciences » speaking at World EPA Congress

Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health

Goedele Van Haasteren | Staff Member | Swiss Federal Office of Public Health » speaking at World EPA Congress

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani | Medical Advisor | CZ » speaking at World EPA Congress

Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Kärt Veliste | Chief Specialist at Department of Medicines and Medical Devices | Haigekassa Estonia » speaking at World EPA Congress

Natasa Zibelnik, Global Head of Value, Access and Pricing, Eusa Pharma

Natasa Zibelnik | Global Head of Value, Access and Pricing | Eusa Pharma » speaking at World EPA Congress

Zinajda Zolic-Karlsson, Senior Advisor HTA and Reimbursement, Norwegian Medicines Agency

Zinajda Zolic-Karlsson | Senior Advisor HTA and Reimbursement | Norwegian Medicines Agency » speaking at World EPA Congress

Get Involved 
 

To Sponsor Or Exhibit


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

To Speak


Francesca Wiggins
francesca.wiggins@terrapinn.com